腫瘍細胞によるインタールイキン-2の生成は,抗腫瘍応答の生成において,Tヘルパー機能をバイパスする
E R Fearon1, D M Pardoll, T Itaya
1Department of Oncology School of Medicine, Johns Hopkins University, Baltimore, Maryland 21205.
Cell
|February 9, 1990
まとめ
インタールイキン-2 (IL-2) を分泌する人工腫瘍細胞は,強力な抗腫瘍免疫反応を刺激し,免疫不全が,エフェクター細胞の欠如ではなく,がん免疫を阻害することを実証しました. このアプローチは,抗腫瘍免疫を強化するための新しい戦略を提供します.
科学分野:
- 免疫学 免疫学とは
- 腫瘍学 腫瘍学
- がん研究 がん研究
背景:
- 免疫性の低いネズミの結腸がんモデルを使用して,抗腫瘍免疫のメカニズムを調査した.
- 確立された腫瘍に対する弱い免疫応答の課題に取り組んだ.
研究 の 目的:
- 抗腫瘍免疫を強化するための新しい戦略を探求する.
- 腫瘍細胞によるサイトカインの分泌が効果的な免疫反応を刺激できるかどうかを判断する.
主な方法:
- 腫瘍細胞の遺伝子転移により,インタールイキン-2 (IL-2) が分泌される.
- 抗腫瘍反応と腫瘍への挑戦に対する保護を評価するインビボ研究.
- CD4+T細胞の存在と欠如における免疫応答の評価.
主要な成果:
- IL-2を分泌する腫瘍細胞は,メジャー・ヒストコンパティビリティ・コンプレックス (MHC) のクラスI制限型細胞分解性Tリンパ球 (CTL) 応答を誘導した.
- 抗腫瘍反応は,CD4+T細胞なしでも,in vivoで観察されました.
- エンジニアリング細胞による予防接種は,後の腫瘍への挑戦から保護を与えました.
結論:
- 効果的な抗腫瘍免疫の主要な制限は,免疫ヘルパー機能の欠乏であり,細胞毒性エフェクター細胞の欠如ではないかもしれません.
- ヘルパーリンフォキンのパラクリン提供は,腫瘍特異の免疫反応を誘発することができます.
- この戦略は,腫瘍の免疫を強化するための新しいアプローチを提供します.
関連する概念動画
Cell-mediated Immune Responses
65.0K
Overview
65.0K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
T Cell Activation and Clonal Selection
13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Cytotoxic T Cells-mediated Immune Response
7.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.1K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K


